Gambro to host symposium at the 25th Annual Congress of European Society of Intensive Care Medicine: New clinical perspectives on the management of critically ill patients with acute kidney injuryOct 13, 2012 09:00 BST
The congress is one of the major intensive care meetings taking place in 2012, hence an important venue as Gambrohas a leading position in the Acute segment.
Gambro will host an Industry Lunch Symposium entitled: “New clinical perspectives on the management of critically ill patients with acute kidney injury”. The symposium will take place Monday, October 15, 12.30–14.00, venue: Room Lisbon
Chair: Prof Marco Maggiorini, UniversitätsSpital,Zürich,Switzerland
The KDIGO AKI Guideline: Implications for Clinical Practice, Prof. Daniel De Backer, Hôpital Erasme,Brussels,Belgium
Renal Recovery After Acute Kidney Injury: Clinical and Health Economic Considerations, Dr. Max Bell Karolinska University Hospital,Stockholm,Sweden
The evidence base pertaining to the management of critically ill patients with acute kidney injury (AKI) continues to evolve. In this symposium, experts will focus on two recent developments specifically in the area of renal replacement therapy (RRT) for AKI. First, RRT-related consensus statements from the recently issued KDIGO AKI Guideline will be discussed, with particular emphasis on modality choice and anticoagulation. In the second presentation, emerging data which strongly suggest a benefit for CRRT over intermittent RRT modalities with respect to renal recovery after AKI will be presented. Both the clinical and health economic implications of these new data will be discussed.
Furthermore, visitors will be able to visit Gambro’s exciting exhibition with focus on FleXitrate full citrate-calcium CRRT. Products on display will be Prismaflex and MARS machines, as well as solutions. Also, the scientific messages will be further reinforced in the Gambro booth, containing a dedicated scientific corner.
Let us share our experience and knowledge with you and discuss it further.
Please visit our booth no 16 in exhibition area A.
For more information about Gambro at the ESICM please read here
Gambro media relations
Gambro is a global medical technology company and a leader in developing, manufacturing and supplying products and therapies for Kidney and Liver dialysis, Myeloma Kidney Therapy, and other extracorporeal therapies for Chronic and Acute patients. Gambro was founded in 1964 and has today 7 500 employees, 13 production facilities in 9 countries, and sales in more than 100 countries.
Follow us on twitter http://twitter.com/#!/gambrocorporate